Table 3.
Persentage of cell viability following the administration of curcumin, genistein and combination (n =3)
| No | Treatment | % viability ± SE |
|---|---|---|
| 1 |
Curcumin 10 μM |
83.66 ± 8.24 |
| 2 |
Genistein 5 μM |
191.80 ± 8.94 |
| 3 |
Genistein 10 μM |
171.22 ± 6.63 |
| 4 |
Genistein 20 μM |
90.41 ± 2.13 |
| 5 |
Genistein 50 μM |
38.72 ±3.99 |
| 6 |
Curcumin 10 μM + Genistein 20 μM* |
10.88 ± 1.85 |
| 7 |
Curcumin 10 μM + Genistein 50 μM* |
2.40 ± 0.59 |
| 8 |
Curcumin 10 μM + Genistein 20 μM** |
43.49 ± 4.90 |
| 9 | Curcumin 10 μM + Genistein 50 μM** | 15.83 ± 0.88 |
** Curcumin and genistein were added at the same time. * Genistein was added 16 hours after the addition of curcumin. These data represent minimal two independent experiments.